Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs1882543 | chr12:107067160 | A/G | 5.07E-5 | 134 | 28.67 | 42.02 | 45.93 | KM Plot |
| TGCT | rs189441 | chr17:39367743 | A/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs1922432 | chr12:107077232 | G/A | 7.21E-5 | 129 | 46.77 | 45.47 | 28.67 | KM Plot |
| TGCT | rs1922433 | chr12:107077172 | A/G | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs1922435 | chr12:107082455 | A/G | 0.000103 | 134 | 42.18 | 45.83 | 28.8 | KM Plot |
| TGCT | rs1922436 | chr12:107065258 | A/G | 0.000103 | 134 | 42.27 | 45.47 | 28.8 | KM Plot |
| TGCT | rs1922438 | chr12:107085171 | C/G | 0.000103 | 134 | 42.27 | 45.47 | 28.8 | KM Plot |
| TGCT | rs1930960 | chr10:27564826 | G/C | 8.0E-7 | 131 | 42.18 | 46.07 | 20.6 | KM Plot |
| TGCT | rs1959477 | chr14:71034216 | A/G | 1.43E-5 | 133 | 39.38 | 65.47 | 21.43 | KM Plot |
| TGCT | rs1968916 | chr2:99861530 | C/T | 0.000122 | 133 | 42.18 | 66.9 | 30.55 | KM Plot |
| TGCT | rs1969755 | chr6:15221395 | G/A | 7.25E-5 | 131 | 37.62 | 45.1 | NA | KM Plot |
| TGCT | rs199724778 | chr17:39345144 | CAA/C | 7.48E-7 | 132 | 13.17 | 46.03 | 43.68 | KM Plot |
| TGCT | rs200498927 | chr16:27801022 | T/TGGAC | 0.000168 | 128 | 46.77 | 33.05 | 17.87 | KM Plot |
| TGCT | rs200805418 | chr6:42551730 | ATTTT/A | 5.0E-8 | 128 | 20.6 | 50.8 | 38.2 | KM Plot |
| TGCT | rs200827597 | chr16:67666028 | T/TTCAGAAA | 0 | 133 | 46.07 | 24.1 | 0.57 | KM Plot |